Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR2 | P30518 | 15/20 | 0.42 |
| ▸ | AVPR1A | P37288 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.37 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.37 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.37 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.37 |
| ▸ | PRKAG3 | Q9UGI9 | 1/20 | 0.37 |
| ▸ | PRKAG2 | Q9UGJ0 | 1/20 | 0.37 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.37 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7111249 | 0.86 | AVPR2 (0.45) | AVPR2AVPR1A | |
| SCHEMBL5784142 | 0.84 | AVPR2 (0.57) | AVPR2AVPR1AALDH1A1TP53MAPT | |
| SCHEMBL7114677 | 0.84 | AVPR2 (0.49) | AVPR2AVPR1AALDH1A1TP53MAPT | |
| SCHEMBL5842796 | 0.83 | AVPR2 (0.43) | AVPR2AVPR1AALDH1A1TP53MAPT | |
| SCHEMBL5785589 | 0.82 | AVPR2 (0.45) | AVPR2AVPR1AALDH1A1TP53MAPT | |
| SCHEMBL5785393 | 0.82 | AVPR2 (0.49) | AVPR2AVPR1AALDH1A1TP53MAPT | |
| SCHEMBL5783256 | 0.82 | AVPR2 (0.55) | AVPR2AVPR1AALDH1A1TP53MAPT | |
| SCHEMBL5785436 | 0.81 | AVPR2 (0.47) | AVPR2AVPR1AALDH1A1TP53MAPT | |
| SCHEMBL5835574 | 0.81 | TSHR (0.43) | AVPR2AVPR1AALDH1A1TP53MAPT | |
| SCHEMBL5785079 | 0.81 | AVPR2 (0.42) | AVPR2AVPR1AALDH1A1TP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030008863-A1 | Novel tricyclic diazepines tocolytic oxytocin receptor antagonists | WYETH | 2003-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030008863-A1 | Novel tricyclic diazepines tocolytic oxytocin receptor antagonists | OXTR, OPRL1, HCRTR2 | AVPR2 91/4885AVPR1A 62/4885ALDH1A1 3354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.